Published in J Gen Intern Med on December 13, 2007
Hyperammonemia in review: pathophysiology, diagnosis, and treatment. Pediatr Nephrol (2011) 1.22
Refeeding encephalopathy in a patient with severe hypophosphataemia and hyperammonaemia. Eur J Clin Nutr (2014) 1.10
Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. J Inherit Metab Dis (2012) 0.90
Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt. World J Gastroenterol (2014) 0.90
Fatal Nonhepatic Hyperammonemia in ICU Setting: A Rare but Serious Complication following Bariatric Surgery. Case Rep Crit Care (2016) 0.83
Carnitine deficiency presenting with encephalopathy and hyperammonemia in a patient receiving chronic enteral tube feeding: a case report. J Med Case Rep (2012) 0.81
Failure of carnitine in improving hepatic nitrogen content in alcoholic and non-alcoholic malnourished rats. Clinics (Sao Paulo) (2010) 0.75
Carnitine deficiency presenting with a decreased mental state in a patient with amyotrophic lateral sclerosis receiving long-term tube feeding: a case report. J Med Case Rep (2013) 0.75
L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. Neurochem Res (2017) 0.75
Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr (2004) 2.83
Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem (1998) 2.05
Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology (2000) 1.61
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet (1999) 1.61
Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci (2004) 1.55
Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis. Pediatrics (1980) 1.43
Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr (1982) 1.29
Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet (1999) 1.19
Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome. J Clin Invest (1988) 1.16
Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology (1974) 1.16
Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr (2001) 1.13
Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res (1983) 1.13
The carnitine acyltransferases and their role in modulating acyl-CoA pools. Arch Biochem Biophys (1993) 1.11
The nutritional relationship linking sulfur to nitrogen in living organisms. J Nutr (2006) 1.09
Carnitine transport: pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis (2003) 1.08
Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency. Mol Genet Metab (2005) 1.08
Regulation of mitochondrial carbamoyl-phosphate synthetase 1 activity by active site fatty acylation. J Biol Chem (2001) 1.00
Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. Clin Chim Acta (2000) 0.95
Serum carnitine during valproic acid therapy. Epilepsia (1986) 0.93
Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam. Acta Neurol Scand (2004) 0.89
Systemic carnitine deficiency simulating recurrent Reye syndrome. J Pediatr (1980) 0.89
Correlation of carnitine levels to methionine and lysine intake. Physiol Res (2000) 0.87
Reye's syndrome in the adult: case report and review of the literature. Am J Gastroenterol (1983) 0.86
Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res (1999) 0.82
Carnitine status in Reye and Reye-like syndromes. Pediatr Neurol (1989) 0.82
Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy. J Pediatr (1986) 0.82
Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities. Eur J Pediatr (1984) 0.80
Systemic carnitine deficiency: clinical, biochemical, and morphological cure with L-carnitine. Neurology (1984) 0.79
Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol (2005) 0.79
Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res (1997) 0.79
Fifteen years' experience with 212 hyperammonaemic cases at a metabolic unit. J Inherit Metab Dis (1991) 0.78
Effects of L-carnitine on urea synthesis following acute ammonia intoxication in mice. Biochem Biophys Res Commun (1984) 0.78
Hyperammonemia during total parenteral nutrition in children. JPEN J Parenter Enteral Nutr (1982) 0.78
Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy. Clin Exp Pharmacol Physiol (2006) 0.78
Carnitine prevents Reye-like syndrome in atypical carnitine deficiency. Pediatr Neurol (1989) 0.77
Prognostic factors of hepatic encephalopathy after portacaval anastomosis: a multivariate analysis in 50 patients. Am J Gastroenterol (1992) 0.77
Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology (2004) 1.17
Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol (2005) 1.11
Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer (2004) 0.99
Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor. Carcinogenesis (2010) 0.84
Whomsoever ignores the natural history of the hepatitis C virus is doomed to treat it. Gastroenterology (2002) 0.84
Hypercholesterolemia in primary biliary cirrhosis: getting to the heart of the matter? Gastroenterology (2003) 0.82
Use of a standardized patient exercise to assess core competencies during fellowship training. J Grad Med Educ (2010) 0.82
Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. J Clin Densitom (2006) 0.80
Cirrhosis-associated mortality: frankly, scarlet, do we really make a damn? Gastroenterology (2006) 0.77
Liver emergencies during pregnancy. Gastroenterol Clin North Am (2003) 0.76
Can de-bugging the system prevent complications of cirrhosis? The answer may be no. Gastroenterology (2004) 0.76
Ironing out the cryptic intestinal defect in hereditary hemochromatosis. Gastroenterology (2005) 0.75
Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology (2004) 0.75
Is it HELLPful to consider the hanging LCHAD in pregnancy-associated liver disease? Gastroenterology (2003) 0.75
Response to Rigato et al.: bilirubin and non-hepatic disease--a jaundiced view. Trends Mol Med (2005) 0.75
Hepatitis C infection with normal transaminases: is the treatment worse than the disease? Gastroenterology (2004) 0.75
A role for the appendix in inflammatory bowel disease? Cut it out. Gastroenterology (2003) 0.75
Giant cell hepatitis in a teenage woman. Clin Gastroenterol Hepatol (2008) 0.75
Some TIPS for the prevention of recurrent variceal hemorrhage? Gastroenterology (2002) 0.75
Combination therapy for chronic hepatitis B: a one-two knockout punch, or a swing and a miss? Gastroenterology (2006) 0.75
All kidding aside with the use of lamivudine in children with chronic hepatitis B. Gastroenterology (2002) 0.75